August 4, 2011 – Published last week in The American Journal of Roentgenology, researchers from Swedish Cancer Institute and the University of Washington used positron emission mammography (PEM) to find a correlation between fludeoxyglucose (FDG) uptake values and the prognostic factors that predict breast cancer survival. The highest FDG levels were in the most aggressive cancer type – triple negative cancers. Women with triple negative breast cancer have a higher mortality because there is no tailored therapy available to them. PEM may now benefit this patient population as it may help identify when a chemotherapeutic regimen is not working. PEM also has the potential to play a role in initial staging of breast cancer in patients at high risk for multifocal or multicentric disease who desire breast conservation therapy as an alternative to breast MRI.

August 4, 2011 – IBA announced at the recent American Association of Physicists in Medicine (AAPM) annual meeting in Vancouver, British Columbia, that it has enabled Cape Cod Hospital in Hyannis, Mass., to open its hospital’s radiation therapy vault quickly and efficiently and therefore treat a greater number of cancer patients. IBA provided radiation therapy commissioning services with its Blue Phantom solution and advanced linear diode array (LDA-99) technology.

August 4, 2011 – To improve patient health through safe and efficient use of radioactive materials during handling, diagnosis and therapy, many nuclear pharmacies use the Biodex Medical Systems’ Atomlab dose calibrator. Biodex spoke with Brett Whittacre, president of BioDose, Las Vegas, a provider of nuclear medicine management systems, about some of the objectives of a busy pharmacy and how the Atomlab’s new features can help hospitals and labs meet their goals.

August 4, 2011—The first multi-institutional study evaluating a new form of radiation treatment for prostate cancer coupled with sophisticated real-time tumor tracking is now underway at the University of Michigan Health System in Ann Arbor, Mich. Principal investigator Daniel A. Hamstra, Ph.D., M.D., assistant professor, department of radiation oncology, along with 10 co-investigators, are evaluating the safety of shortened (hypofractionated) stereotactic body radiation therapy (SBRT) with Calypso Medical’s GPS for the Body technology, used for real-time tracking of cancerous tumors during prostate radiotherapy, and comparing it to conventional radiation treatment.

August 3, 2011 — Siemens Healthcare announced that its syngo.via advanced visualization software will be exclusively used by researchers from the National Center for Image Guided Therapy (NCIGT) at Brigham and Women’s Hospital (BWH) in Boston.

August 3, 2011 - The latest release of McKesson's radiology information system (RIS) and picture archiving and communication system (PACS)  have both infrastructure updates and usability enhancements. These systems offer value for medical imaging workflow.

August 2, 2011 – As the 2011 American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP) meet in Vancouver, Canada, GE Healthcare announced the recent U.S. Food and Drug Administration (FDA) clearance and increasing global utilization of its new platform of radiotherapy (RT) planning computed tomography (CT) systems. Highlighted by the Discovery CT590 RT, these CT systems are designed specifically with treatment planning in mind and help physicians address the increasingly specialized imaging needs of patients.

August 2, 2011 – Two new studies published in the August 2011 issue of The Journal of Nuclear Medicine (JNM) provide insight into the potential of positron emission tomography (PET) to differentiate between types of dementia and to identify pharmaceuticals to slow the progress of dementia. With proposed National Institute on Aging (NIA) and the Alzheimer's Association guidelines for detecting Alzheimer's-related brain changes expected in September, these articles give a preview of what may be to come.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now